US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO – Journal of Medical Internet Research (JMIR)
- US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO Journal of Medical Internet Research (JMIR)
- FDA Warns Against “Over-Reliance” on AI Pharmaceutical Manufacturing . . . But How Much Reliance Is Too Much? The National Law Review
- Artificial Intelligence, Virtual Participants, and the Evolving FDA Regulatory Landscape Clinical Leader
- The FDA Is Encouraging AI Data in Clinical Trials Black Doctor
- FDA’s HALO Platform And Elsa 4.0: Five Critical Risks For Sponsors Clinical Leader
0
مشاهدة
